Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03552107 · ClinicalTrials.gov registry record
Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic
A clinical trial of Obesity and Overweight, sponsored by Scripps Whittier Diabetes Institute.
- Completed
- Registry status
- 157
- Enrollment target
- 1
- Study location
NCT03552107 is a study of Obesity and Overweight that has completed, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 157 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03552107, a study of Obesity and Overweight, has completed, sponsored by Scripps Whittier Diabetes Institute.
- COMPLETED
- Registry status
- 157 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective, descriptive study that involves de-identified data consisting of weight changes, pertinent vital signs and laboratory values influenced by body weight, and healthcare utilization of patients prescribed lorcaserin at The Center for Weight Management at the Scripps Clinic in San Diego, CA.
Conditions Studied
Interventions
- DRUG Lorcaserin
Study Locations (1)
California
- Scripps Whittier Diabetes Institute - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2019-04-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03552107
The ClinicalTrials.gov registry entry for NCT03552107 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (81% lower). The listed sponsor is Scripps Whittier Diabetes Institute, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Lorcaserin is the first listed.
NCT03552107 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03552107 about?
NCT03552107 is a clinical study titled "Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic". This is a retrospective, descriptive study that involves de-identified data consisting of weight changes, pertinent vital signs and laboratory values influenced by body weight, and healthcare utilization of patients prescribed lorcaserin at The Center for Weight Management at the Scripps Clinic in S...
What is the current status of trial NCT03552107?
This trial is currently completed. The enrollment target is 157 participants. The study started on 2017-04-11. Estimated completion is 2019-04-11.
What conditions does trial NCT03552107 study?
This clinical trial studies the following conditions: Obesity, Overweight, Weight Loss.
What interventions are being tested in trial NCT03552107?
The interventions under investigation include: Lorcaserin (DRUG).
Who is sponsoring clinical trial NCT03552107?
This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03552107 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.